Healthcare | February 15, 2024
Mankind Pharma tie-ups with Lepra Society to establish CDCC Centres to screen 80,000 individuals
The CDCCs are strategically positioned in regions identified as high-impact areas
The CDCCs are strategically positioned in regions identified as high-impact areas
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
The new campus has been designed as an employee-centred experience and ecosystem zone
An accomplished R&D leader and champion of the application of AI to drug discovery
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)
Subscribe To Our Newsletter & Stay Updated
